1. A phase 1, randomized, observer blind, antigen and adjuvant dosage finding clinical trial to evaluate the safety and immunogenicity of an adjuvanted, trivalent subunit influenza vaccine in adults ≥ 65 years of age. Issue 3 (16th January 2020) Authors: Otten, Gillis; Matassa, Vincent; Ciarlet, Max; Leav, Brett Journal: Vaccine Issue: Volume 38:Issue 3(2020) Page Start: 578 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗